PTO-1390 (03-13)
`Approved for use through 4/30/2013. OMB 0651-0021
`U. 3 Patent and Trademark Office; US, DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`TRANSMITTAL LETTER TO THE UNITED STATES
`DESIGNATED/ELECTED OFFICE (DO/EOIUS)
`CONCERNING A SUBMISSION UNDER 35 U.S.C. 371
`
`Attorney DOCkeY N04
`US. Application Nofiikiiifiigy CFR 15)
`
`27 Janua
`2013
`23 Janua
`PCT/JP2013/000311
`METHOD AND SYSTEM FOR DiAGNOSiNG ALZHEiMER‘S DiSEASE
`
`2012
`
`First Named inventor
`
`Takaomi FUKU HARA
`
`
`Applicant herewith submits to the United States Designated/Elected Office (DOIEO/US) the following items and other information.
`X This is an express request to begin national examination procedures (35 U.S.C. 371(0). NOTE: The express request under
`
`1 .
`35 U.S.C. 371m will not be effective unless the requirements under 35 U.S.C. 371(c)(1), (2). and (4) for payment of the basic
`national fee, copy of the International Application and English translation thereof (if required), and the oath or declaration of
`the inventor(s) have been received
`
`A copy ofthe international Application (35 U.S.C. 371(c)(2)) is attached hereto (not required lithe international Application
`was previously communicated by the international Bureau or was filed in the United States Receiving Office (RD/US».
`
`
`
`
`
`
`
`
`
` Do not enter the amendment made in the international phase under PCT Article 34,
`
` 37 CFR 3.73(c) Statement (when there is an Assignee).
`
`
`
`An English language translation of the International Application (35 U.S.C. 371(c)(2)),
`
`X is attached hereto
`
`
`has been previously submitted under 35 U.S.C. 154( )(4).
`
`
`An oath or declaration of the inventor(s) (35 U.S.C. 371(c)(4)).
`
`is attached.
`
`was previously filed in the international phase under PCT Rule 4.17(iv).
`
`items 5 to 8 below concern amendments made in the international phase:
`PCT Article 19 and 34 amendments
`
`
`
`Amendments to the claims under PCT Article 19 are attached (not required if communicated by the international Bureau)
`(35 U.S.C. 371(c)(3))
`
`English translation of the PCT Article 19 amendment is attached (35 U.S.C. 371(c)(3)).
`
`
`
`English translation of annexes (Article 19 and/or 34 amendments only) of the international Preliminary Examination Report is
`attached (35 USC. 371(c)(5)).
`
`
`Cancellation of amendments made in the international phase
`8a.
`
`Do not enter the amendment made in the international phase under PCT Article 19.
`
`8b,
`
`
`
`NOTE: A proper amendment made in English under Article 19 or 34 will be entered in the US. national phase application absent a clear
`instruction from applicant not to enter the amendment(s).
`
`The following items 9 to 17 concern a document(s) or information included:
`
`9.
`An information Disclosure Statement under 37 CFR 197 and 1.98.
`
`
`A preliminary amendment,
`
`
`
`
`
`
`
`
`
`
`An Application Data Sheet under 37 CFR 1.76.
`
`A substitute specification. NOTE: A substitute specification cannot include claims See 37 CFR 1125(b),
`
`A power of attorney and/or change of address letter,
`
`A computer-readable form of the sequence listing in accordance with PCT Rule 13ter.3 and 37 CFR 1821—1825.
`
`Assignment papers (cover sheet and document(s)). Name of Assignee:
`
`PANASONIC HEALTHCARE CO, LTD.
`SHIGA UNIVERSITY OF MEDICAL SCIENCE
`
`
`
`Page 1 of 3
`
`10.
`
`11V
`
`12.
`
`13.
`
`14.
`
`15V
`
`16.
`
`

`

`
`
`
`
`
`
`19,
`
`Examination fee (37 CFR 1.492(0))
`If the written opinion prepared by lSA/US or the international preliminary
`examination report prepared by IPEA/US indicates all claims satisfy provisions of
`PCT Article 33(1)»(4) ................................................ $0
`
`All other situations
`ttttt $720
`
`
`
`
`PTO-1390 (03—13)
`Approved for use through 4/30/1201 3. OMB 0651-0021
`U. 8. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`0 s APPLN. No (it known, see 37 CFR 1 5)
`INTERNATlONAL APPLICATION No.
`ATTORNEY DOCKET No.
`
`PCT/JP2013/000311
`0613520530
`
`
`
`
`Other items or information:
`
`PUB Publication; lSR
`
`17.
`
`
`
`The following fees have been submitted.
`CALCULATIONS
`PTO USE ONLY
`
`18. X Basic national fee (37 CFR 1.492(a)) .......................................................... $280
`$
`280.00
`
`Search fee (37 CFR 1.492(b))
`if the written opinion prepared by ISA/US or the international preliminaw
`examination report prepared by lPEA/US indicates all claims satish/ provisions of
`PCT Article 33(1)~(4)
`........................................................................................................ $0
`Search fee (37 CFR 1.445(a)(2)) has been paid on the international application to
`the USPTO as an international Searching Authority ..................................................... $120
`International Search Report prepared by an ISA other than the US and provided to
`the Office or previously communicated to the US by the lB ......................................... $480
`
`All other situations .......................................................... $600
`
`TOTAL OF 18,19 and 20 =
`1,480.00
`
`
`
`
`[:1 Additional fee for specification and drawings filed in paper over 100 sheets
`(excluding sequence listing in compliance with 37 CFR 1.821(c) or (e) or in an
`electronic medium or computer program listing in an electronic medium) (37 CFR
`1.492(1)).
`
`Fee for each additional 50 sheets of paper or fraction thereof ...........................................$400
`
`Total Sheets
`Extra Sheets
`Number of each addition 50 or fraction
`RATE
`thereof (round up to a whole number)
`
`
`
`
`
`-100 =
`
`/50 =
`
`X $400
`
`Surcharge of $140.00 for furnishing any of the search fee. examination fee, or the oath or
`
`declaration after the date of commencement of the national stage (37 CFR 1.492( )).
`
`CLAIMS
`1
`NUMBER FILED
`NUMBER EXTRA
`RATE
`Total claims
`1
`13 - 20 =
`0
`X
`$80
`Independent claims
`i
`3 . 3 =
`0
`x $420
`MULTIPLE DEPENDENT CLAIM(S) (if applicable)
`+ $780
`
`
`
`Processing fee of $140.00 for furnishing the English translation later than 30 months from the
` 7
`earliest claimed priority date (37 CFR 1.492(0).
`+
`
`
`TOTAL OF ABOVE CALCULATIONS =
`1,480.00
`
`
`Applicant asserts small entity status. See 37 CFR 127'. Fees above are reduced by 1/2.
`
`Applicant certifies micro entity status. See 37 CFR 1.29. Fees above are reduced by 34.
`Applicant must attach form PTO/SB/15A or B or equivalent,
`
`
`
`
`
`
`
`TOTAL NATIONAL FEE = 1,480.00
`
`Fee for recording the enclosed assignment (37 CFR 1.21(h)). The assignment must be
`accompanied by an appropriate cover sheet (37 CFR 328, 3.31), $40.00 per property
`
`
`
`
`TOTAL FEES ENCLOSED = 1,480.00
`Amount to be
`refunded:
`Amount to be
`charged
`
`
`
`Page 2 of 3
`
`

`

`PTO«1390 (03-13)
`Approved for use through 4/30/2013. OMB 0651-0021
`U. 8. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`A check in the amount of $
`
`to cover the above fees is enclosed.
`
`Please charge my Deposit Account No.
`
`50-0417
`
`in the amount of $
`
`1,480.00
`
`to cover the above fees.
`
`The Director is hereby authorized to charge additional fees which may be required, or credit any overpayment, to Deposit
`
`Account No.
`50-0417
`as follows:
`
`
`any required fee,
`
`
`
`
`
`
`
`
`
`(Attorney/Agent) Registration No.
`
`any required fee except for excess claims fees required under 37 CFR 1.492(d) and (e) and multiple dependent claim fee
`required under 37 CFR 1.492(f).
`
`Fees are to be charged to a credit card. WARNING: Information on this form may become public. Credit card information should not
`be included on this form. Provide credit card information and authorization on PTO—2038. The PTO‘2038 should only be mailed or
`faxed to the USPTO. However, when paying the basic national fee, the PTO-2038 may NOT be faxed to the USPTO.
`
`ADVISORY: if filing by EFS—Web, do NOT attach the PTO—2038 form as a PDF along with your EFS—Web submission. Please be
`advised that this is not recommended and by doing so your credit card information may be displayed via PAIR. To protect your
`information, it is recommended to pay fees online by using the electronic payment method.
`
`NOTE:
`Where an appropriate time limit under 37 CFR 1.495 has not been met, a petition to revive (37 CFR 1.137(a) or (b)) must be filed
`and granted to restore the International Application to pending status.
`
`Statement under 37 CFR 1.55 or 1.78 for NA (First inventor to File)Transition Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013, and (2) also contains, or contained at
`any time, a claim to a claimed invention that has an effective filing date on or after March 16,2013.
`NOTE:
`A US. national stage application may not claim priority to the international application of which it is the national phase. The filing date
`of a US. national stage application is the international filing date. See 35 U.S.C. 363.
`Correspondence Address
`
`
`
`Correspondence address below
`The address associated with Customer Number:
`
`
`
`
`Name
`
`
`Address
`
` Zip Code
`City
`
`
` Telephone
`Country
`Email
`
`
`
`Signature July23,2014 r i V
`
`Name
`-
`(Printhype)
`
`
`
`
`
`
`
`'
`
`35 139
`
`Page 3 of 3
`
`